Ty Gluckman, MD: Disparities in Care Despite Increased Technology Use


In part 2 of an interview with HCPLive, Ty Gluckman, MD discusses both the advantages and disadvantages of technology replacing traditional care.

In part 2 of an interview with HCPLive, Ty Gluckman, MD, discussed his own perspective on both the potential and challenges of the rollout of new digital tools for cardiovascular care, noting his own involvement in an ASCVD risk estimator app.

Gluckman moderated "Practical Strategies in Practice" as part of the American Society for Preventive Cardiology’s 2021 Virtual Summit on CVD Prevention.

"We're challenged by parts of the country demographics of patients based often on where they live, that may not have access to broadband, or the ability to be able to even collect and transmit the information," Gluckman said.

However, he noted the usefulness of devices, such as smartphones, in collecting data and sharing information to be able to keep patients engaged in their care.

"I think just as important as that technology is advancing and us understanding how to utilize it," Gluckman said. "There has to be a regulation or regulatory component of this to make sure that the devices that are being used are accurate."

Gluckman also spoke on the role of telehealth, regarding both its challenges and positives as a clinician treating patients during the COVID-19 pandemic, noting that clinicians are nascent into the process.

He observed part of the challenge was the need to pivot for experts who had never done a telehealth visit before, but he found that there was also a level of insight into patients that had never existed before.

"Figuring out how we on the healthcare delivery side connect between primary care and specialists to be able to provide information, without the necessity to have patients seen by a specialist provides a lot of value," Gluckman said. "Remote patient monitoring and telehealth visits, all of these things are going to increasingly gain greater importance."

Find part 1 of the interview here.

Related Videos
HCPLive Five at APA 2024 | Image Credit: HCPLive
Video 6 - "Evaluating Safety of Novel LDL Management Mechanism"
Video 5 - "Optimizing PCSK9 Inhibitors and Analyzing Plaque Reduction Data"
John M. Oldham, MD: A History of Personality Disorder Pathology
Franklin King, MD: Psychedelic Therapy History, Advances, and Hurdles
© 2024 MJH Life Sciences

All rights reserved.